Ep. 87: Taking a Customized and Collaborative Approach to Therapeutic Development

The N=1 Collaborative is changing the way we view drug development. Their specialty is creating customized therapies tailored to individual patients, paving the way for a unique approach that can leave long-lasting impacts on those with ultra-rare diseases.  

 

Join us as Executive Director Hugh Hempel discusses the origins of N=1, the collaborative effort it takes to advance customized therapies down the pipeline, and what the future holds for the field of individualized medicine.

Show Notes  

  

n=1 Collaborative 

Rare Disease | Charles River 

Rare Disease Research for Drug Development 

Repurposing Drugs for Rare Disease 

S4 E07: Free For Life: The Story of N-Lorem Foundation 

What is Sounds of Science?

Sounds of Science is a monthly podcast about beginnings: how a molecule becomes a drug, how a rodent elucidates a disease pathway, how a horseshoe crab morphs into an infection fighter. The podcast is produced by Eureka, the scientific blog of Charles River, a contract research organization for drug discovery and development. Tune in and begin the journey.